2023 AACC (ADLM) | BIOTEST HIGHLIGHTS

 

 

The 75th Annual American Association for Clinical Chemistry and Clinical Laboratory Medicine Expo (AACC) was held at the Anaheim Convention Center in Anaheim, California, USA, from 25th to 27th July, local time. On the eve of the show's opening, the American Association for Clinical Chemistry (AACC) announced that it will officially change its name to Association for Diagnostics & Laboratory Medicine (ADLM). The new name will more accurately reflect the diversity of the membership and be more inclusive of all professionals and clinical chemists engaged in the clinical laboratory industry and related work. ADLM is currently one of the world's most internationally influential annual event in the field of clinical testing, focusing on the industry's new concepts, new technologies, new products, bringing together 941 exhibitors from more than 100 countries and regions around the world. More than 20,000 laboratory professionals gathered on the scene to seek new directions for the development of clinical testing.

Biotest Biotech and its US subsidiary ADVIN Biotech formed a core marketing team to attend the event. At the AACC show, the company showcased a number of key new products and devices. Key new products include SalivaTracer, a new micro saliva drug test panel, new single-sided and double-sided saliva drug test cups, xylazine drug rapid test reagent, Carfentanil drug rapid test reagent and so on. New equipment included a new microfluidic testing instrument. Other highlights include the American 510K series products, pet testing series products, and fluorescence quantitative testing series products.

During the exhibition, several new products released by Biotest triggered great attention and interest from customers. Through more in-depth communication with customers, the team of Biotest learned more comprehensive market information, which guided the company to make further planning and layout at the product level and market level, and laid a solid foundation for the subsequent growth of new business.

Keeping the original intention and moving forward, Biotest is committed to providing innovative, immediate, and high-quality diagnostic products and solutions to satisfy the unexhausted healthcare needs of users around the world. We look forward to seeing you again at ADLM 2024 in Chicago!